公开(公告)号：US20240277745A1

公开(公告)日：2024-08-22

申请号：US18564115

申请日：2022-05-25

Applicant: KOWA COMPANY, LTD

Inventor： Noboru KANETA ,  Ryu OSHIMA ,  Shona Sanchita PENDSE ,  Ryohei TANIGAWA

IPC: A61K31/7048 ,  A61K31/423 ,  A61P1/16

CPC classification number: A61K31/7048 ,  A61K31/423 ,  A61P1/16

Abstract: Pemafibrate, tofogliflozin, or combinations thereof for use in treating human patients with liver diseases, particularly NASH patients suffering from liver stiffness or liver fibrosis, NASH patients with lobular inflammation, NASH patients with elevated LDL-C, and NASH patients with healthy triglyceride levels.